Back to User profile » Dr Antonio Ramírez de Arellano
Papers published by Dr Antonio Ramírez de Arellano:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system
Psota M, Psenkova MB, Racekova N, Ramirez de Arellano A, Vandebrouck T, Hunt B
ClinicoEconomics and Outcomes Research 2017, 9:749-762
Published Date: 12 December 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment
Morillas C, Feliciano R, Catalina PF, Ponte C, Botella M, Rodrigues J, Esmatjes E, Lafita J, Lizán L, Llorente I, Morales C, Navarro-Pérez J, Orozco-Beltran D, Paz S, Ramirez de Arellano A, Cardoso C, Tribaldos Causadias M
Patient Preference and Adherence 2015, 9:1443-1458
Published Date: 14 October 2015
![Noteworthy comment: Disability Adjusted Life Years (DALYs) lost to diabetes as the sum of years of life lost and years lived with disability were estimated by gender and age using country-specific epidemiological data and global disability weights. In spite of data limitations, the estimates reported here show that DALY loss due to diabetes imposes a substantial burden on countries. Cross-national variation in disease epidemiology was the largest source of variation in the burden of diabetes between countries.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study
Darbà J, Kaskens L, Detournay B, Kern W, Nicolucci A, Orozco-Beltrán D, Ramírez de Arellano A
ClinicoEconomics and Outcomes Research 2015, 7:163-171
Published Date: 23 March 2015